Homocysteine to hydrogen sulfide or hypertension

Cell Biochemistry and Biophysics

Volumn 57, Issue 2, 2010, Pages 49-58

  Sen, Utpal ^a   Mishra, Paras K ^a   Tyagi, Neetu ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Homocysteine; Hydrogen sulfide; Hypertension; Vascular remodeling

Indexed keywords

CALCIUM; COLLAGEN; HOMOCYSTEINE; HYDROGEN SULFIDE; NITRIC OXIDE;

BLOOD; CYTOLOGY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; METABOLISM; REVIEW; VASCULAR SMOOTH MUSCLE; COMPLICATION;

CALCIUM; COLLAGEN; HOMOCYSTEINE; HUMANS; HYDROGEN SULFIDE; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE;

EID: 77954142028     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-010-9079-y     Document Type: Review

References (86)

1. Oparil, S., Zaman, M. A., & Calhoun, D. A. (2003). Pathogenesis of hypertension. Annals of Internal Medicine, 139, 761-776.
2. Rolland, P. H., Friggi, A., Barlatier, A., Piquet, P., Latrille, V., Faye, M. M., et al. (1995). Hyperhomocysteinemia-induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations. Circulation, 91, 1161-1174.
3. Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., et al. (1997). A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. New England Journal of Medicine, 336, 1117-1124.
4. Woo, K. S., Chook, P., Lolin, Y. I., Sanderson, J. E., Metreweli, C., & Celermajer, D. S. (1999). Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. Journal of the American College of Cardiology, 34, 2002-2006.
5. Wollesen, F., Brattstrom, L., Refsum, H., Ueland, P. M., Berglund, L., & Berne, C. (1999). Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney International, 55, 1028-1035.
6. Upchurch, G. R., Jr., Welch, G. N., Fabian, A. J., Freedman, J. E., Johnson, J. L., Keaney, J. F., Jr., et al. (1997). Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. Journal of Biological Chemistry, 272, 17012-17017.
7. Dudman, N. P., & Wilcken, D. E. (1983). Increased plasma copper in patients with homocystinuria due to cystathionine beta-synthase deficiency. Clinica Chimica Acta, 127, 105-113.
8. Yoshida, Y., Nakano, A., Hamada, R., Kamitsuchibashi, H., Yamamoto, K., Akagi, H., et al. (1992). Patients with homocystinuria: High metal concentrations in hair, blood and urine. Acta Neurologica Scandinavica, 86, 490-495.
9. Ross, R. (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature, 362, 801-809.
10. Lamping, K. G. (1997). Hypercontractility of vascular muscle in atherosclerosis. Circulation, 96, 4131-4132.
11. Boers, G. H. (2000). Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease. Seminars in Thrombosis and Hemostasis, 26, 291-295.
12. Sutton-Tyrrell, K., Bostom, A., Selhub, J., & Zeigler-Johnson, C. (1997). High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation, 96, 1745-1749.
13. Rodrigo, R., Passalacqua, W., Araya, J., Orellana, M., & Rivera, G. (2003). Homocysteine and essential hypertension. Journal of Clinical Pharmacology, 43, 1299-1306.
14. Lip, G. Y., Edmunds, E., Martin, S. C., Jones, A. F., Blann, A. D., & Beevers, D. G. (2001). A pilot study of homocyst(e)ine levels in essential hypertension: Relationship to von Willebrand factor, an index of endothelial damage. American Journal of Hypertension, 14, 627-631.
15. 2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine gamma-lyase. Science, 322, 587-590.
16. Wang, R. (2002). Two's company, three's a crowd: Can H2S be the third endogenous gaseous transmitter? The FASEB Journal, 16, 1792-1798.
17. Shibuya, N., Mikami, Y., Kimura, Y., Nagahara, N., & Kimura, H. (2009). Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. Journal of Biochemistry, 146, 623-626.
18. Shibuya, N., Tanaka, M., Yoshida, M., Ogasawara, Y., Togawa, T., Ishii, K., et al. (2009). 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxidants and Redox Signaling, 11, 703-714.
19. Abe, K., & Kimura, H. (1996). The possible role of hydrogen sulfide as an endogenous neuromodulator. Journal of Neuroscience, 16, 1066-1071.
20. Hosoki, R., Matsuki, N., & Kimura, H. (1997). The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochemical and Biophysical Research Communications, 237, 527-531.
21. Barber, T., Triguero, A., Martinez-Lopez, I., Torres, L., Garcia, C., Miralles, V. J., et al. (1999). Elevated expression of liver gamma-cystathionase is required for the maintenance of lactation in rats. Journal of Nutrition, 129, 928-933.
22. Zhao, W., Zhang, J., Lu, Y., & Wang, R. (2001). The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO Journal, 20, 6008-6016.
23. 2S biogenesis via alternative trans-sulfuration reactions. Journal of Biological Chemistry, 284, 22457-22466.
24. Yao, K. (1975). Effects of several unusual sulfur-containing amino acids on rat liver cystathionine-gamma-lyase. Physiological Chemistry and Physics, 7, 401-408.
25. Chang, L., Geng, B., Yu, F., Zhao, J., Jiang, H., Du, J., et al. (2008). Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids, 34, 573-585.
26. Cheng, Y., Ndisang, J. F., Tang, G., Cao, K., & Wang, R. (2004). Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. American Journal of Physiology. Heart and Circulatory Physiology, 287, H2316-H2323.
27. Stabler, S. P., Steegborn, C., Wahl, M. C., Oliveriusova, J., Kraus, J. P., Allen, R. H., et al. (2002). Elevated plasma total homocysteine in severe methionine adenosyltransferase I/III deficiency. Metabolism, 51, 981-988.
28. Jakubowski, H. (1999). Protein homocysteinylation: Possible mechanism underlying pathological consequences of elevated homocysteine levels. The FASEB Journal, 13, 2277-2283.
29. McCully, K. S. (1969). Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. American Journal of Pathology, 56, 111-128.
30. McCully, K. S. (1996). Homocysteine and vascular disease. Nature Medicine, 2, 386-389.
31. Tyagi, S. C. (1999). Homocyst(e)ine and heart disease: Pathophysiology of extracellular matrix. Clinical and Experimental Hypertension, 21, 181-198.
32. Boers, G. H., Smals, A. G., Trijbels, F. J., Fowler, B., Bakkeren, J. A., Schoonderwaldt, H. C., et al. (1985). Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. New England Journal of Medicine, 313, 709-715.
33. Wald, D. S., Law, M., & Morris, J. K. (2002). Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ, 325, 1202.
34. Nygard, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997). Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine, 337, 230-236.
35. Nygard, O., Vollset, S. E., Refsum, H., Stensvold, I., Tverdal, A., Nordrehaug, J. E., et al. (1995). Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA, 274, 1526-1533.
36. Malinow, M. R., Levenson, J., Giral, P., Nieto, F. J., Razavian, M., Segond, P., et al. (1995). Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis, 114, 175-183.
37. Jakubowski, H. (2008). The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. Journal of Physiology and Pharmacology, 59(Suppl 9), 155-167.
38. Dayal, S., & Lentz, S. R. (2008). Murine models of hyperhomocysteinemia and their vascular phenotypes. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 1596-1605.
39. Tyagi, S. C., Smiley, L. M., Mujumdar, V. S., Clonts, B., & Parker, J. L. (1998). Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone. Molecular and Cellular Biochemistry, 181, 107-116.
40. Tyagi, S. C., Smiley, L. M., & Mujumdar, V. S. (1999). Homocyst(e)ine impairs endocardial endothelial function. Canadian Journal of Physiology and Pharmacology, 77, 950-957.
41. Distrutti, E., Mencarelli, A., Santucci, L., Renga, B., Orlandi, S., Donini, A., et al. (2008). The methionine connection: Homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. Hepatology, 47, 659-667.
42. Chambers, J. C., McGregor, A., Jean-Marie, J., & Kooner, J. S. (1998). Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet, 351, 36-37.
43. Tsai, J. C., Perrella, M. A., Yoshizumi, M., Hsieh, C. M., Haber, E., Schlegel, R., et al. (1994). Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America, 91, 6369-6373.
44. Upchurch, G. R., Jr., Welch, G. N., Fabian, A. J., Pigazzi, A., Keaney, J. F., Jr., & Loscalzo, J. (1997). Stimulation of endothelial nitric oxide production by homocyst(e)ine. Atherosclerosis, 132, 177-185.
45. Tyagi, N., Gillespie, W., Vacek, J. C., Sen, U., Tyagi, S. C., & Lominadze, D. (2009). Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway. Journal of Cellular Physiology, 220, 257-266.
46. Tyagi, N., Sedoris, K. C., Steed, M., Ovechkin, A. V., Moshal, K. S., & Tyagi, S. C. (2005). Mechanisms of homocysteine-induced oxidative stress. American Journal of Physiology. Heart and Circulatory Physiology, 289, H2649-H2656.
47. Lentz, S. R., Sobey, C. G., Piegors, D. J., Bhopatkar, M. Y., Faraci, F. M., Malinow, M. R., et al. (1996). Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. Journal of Clinical Investigation, 98, 24-29.
48. Miller, A., Mujumdar, V., Shek, E., Guillot, J., Angelo, M., Palmer, L., et al. (2000). Hyperhomocyst(e)inemia induces multiorgan damage. Heart and Vessels, 15, 135-143.
49. Mujumdar, V. S., Smiley, L. M., & Tyagi, S. C. (2001). Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. International Journal of Cardiology, 79, 277-286.
50. Tyagi, S. C. (1998). Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. American Journal of Physiology, 274, C396-C405.
51. Tsai, J. C., Wang, H., Perrella, M. A., Yoshizumi, M., Sibinga, N. E., Tan, L. C., et al. (1996). Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. Journal of Clinical Investigation, 97, 146-153.
52. van Guldener, C., & Stehouwer, C. D. (2000). Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Seminars in Thrombosis and Hemostasis, 26, 281-289.
53. Yang, G., Cao, K., Wu, L., & Wang, R. (2004). Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1. Journal of Biological Chemistry, 279, 49199-49205.
54. Raziel, A., Kornberg, Y., Friedler, S., Schachter, M., Sela, B. A., & Ron-El, R. (2001). Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. American Journal of Reproductive Immunology, 45, 65-71.
55. Zemel, M. B. (2001). Calcium modulation of hypertension and obesity: Mechanisms and implications. Journal of the American College of Nutrition, 20, 428S-435S. (discussion 440S-442S).
56. Fleckenstein-Grun, G., Frey, M., Thimm, F., Hofgartner, W., & Fleckenstein, A. (1992). Calcium overload-an important cellular mechanism in hypertension and arteriosclerosis. Drugs, 44(Suppl 1), 23-30.
57. Vijayagopal, P., & Subramaniam, P. (2001). Effect of calcium channel blockers on proteoglycan synthesis by vascular smooth muscle cells and low density lipoprotein-proteoglycan interaction. Atherosclerosis, 157, 353-360.
58. Schachter, M. (1997). Vascular smooth muscle cell migration, atherosclerosis, and calcium channel blockers. International Journal of Cardiology, 62(Suppl 2), S85-S90.
59. Mujumdar, V. S., Hayden, M. R., & Tyagi, S. C. (2000). Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells. Journal of Cellular Physiology, 183, 28-36.
60. Nagai, Y., Tsugane, M., Oka, J., & Kimura, H. (2004). Hydrogen sulfide induces calcium waves in astrocytes. The FASEB Journal, 18, 557-559.
61. 2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes. American Journal of Physiology. Cell Physiology, 294, C169-C177.
62. Sen, S., & Young, D. (1991). Effect of sodium deprivation on cardiac hypertrophy in spontaneously hypertensive rats: Influence of aging. Journal of Molecular and Cellular Cardiology, 23, 695-704.
63. Packer, C. S., Roepke, J. E., Oberlies, N. H., & Rhoades, R. A. (1998). Myosin isoform shifts and decreased reactivity in hypoxia-induced hypertensive pulmonary arterial muscle. American Journal of Physiology, 274, L775-785.
64. Starkebaum, G., & Harlan, J. M. (1986). Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. Journal of Clinical Investigation, 77, 1370-1376.
65. Heinecke, J. W., Kawamura, M., Suzuki, L., & Chait, A. (1993). Oxidation of low density lipoprotein by thiols: Superoxide-dependent and -independent mechanisms. Journal of Lipid Research, 34, 2051-2061.
66. Poddar, R., Sivasubramanian, N., DiBello, P. M., Robinson, K., & Jacobsen, D. W. (2001). Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: Implications for vascular disease. Circulation, 103, 2717-2723.
67. Bouloumie, A., Bauersachs, J., Linz, W., Scholkens, B. A., Wiemer, G., Fleming, I., et al. (1997). Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension, 30, 934-941.
68. Bosse, H. M., & Bachmann, S. (1997). Immunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Goldblatt hypertension. Hypertension, 30, 948-952.
69. Du, J., Hui, Y., Cheung, Y., Bin, G., Jiang, H., Chen, X., et al. (2004). The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart and Vessels, 19, 75-80.
70. Jeong, S. O., Pae, H. O., Oh, G. S., Jeong, G. S., Lee, B. S., Lee, S., et al. (2006). Hydrogen sulfide potentiates interleukin-1beta-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells. Biochemical and Biophysical Research Communications, 345, 938-944.
71. Jovin, I. S., Wolfe, M. L., Gefter, W. B., Miller, W. T., Aronchick, J. M., Flannery, D. T., et al. (1999). Plasma homocysteine levels are not associated with extent of coronary artery calcification in asymptomatic persons. Circulation, 100, 25-25.
72. Hofmann, M. A., Lu, Y., Ferran, L., Kohl, B., & Schmidt, A. M. (1999). Homocysteine induces vascular activation in vitro and in vivo: Accelerated atherosclerosis develops in apo E null mice with hyperhomocysteinemia. Circulation, 100, 44-44.
73. Matthias, D., Becker, C. H., Riezler, R., & Kindling, P. H. (1996). Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine. Atherosclerosis, 122, 201-216.
74. Majors, A., Ehrhart, L. A., & Pezacka, E. H. (1997). Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 2074-2081.
75. Jourdheuil-Rahmani, D., Rolland, P. H., Rosset, E., Branchereau, A., & Garcon, D. (1997). Homocysteine induces synthesis of a serine elastase in arterial smooth muscle cells from multi-organ donors. Cardiovascular Research, 34, 597-602.
76. Hodgkin, D. D., Gilbert, R. D., Roos, P. J., Sandberg, L. B., & Boucek, R. J. (1992). Dietary lipid modulation of connective tissue matrix in rat abdominal aorta. American Journal of Physiology, 262, R389-394.
77. Dayal, S., & Lentz, S. R. (2007). Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals. Antioxidants and Redox Signaling, 9, 1899-1909.
78. Liu, X., Luo, F., Li, J., Wu, W., Li, L., & Chen, H. (2008). Homocysteine induces connective tissue growth factor expression in vascular smooth muscle cells. Journal of Thrombosis and Haemostasis, 6, 184-192.
79. Mayer, O., Filipovsky, J., Dolejsova, M., Cifkova, R., Simon, J., & Bolek, L. (2006). Mild hyperhomocysteinaemia is associated with increased aortic stiffness in general population. Journal of Human Hypertension, 20, 267-271.
80. Hongfang, J., Cong, B., Zhao, B., Zhang, C., Liu, X., Zhou, W., et al. (2006). Effects of hydrogen sulfide on hypoxic pulmonary vascular structural remodeling. Life Sciences, 78, 1299-1309.
81. Moshal, K. S., Sen, U., Tyagi, N., Henderson, B., Steed, M., Ovechkin, A. V., et al. (2006). Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway. American Journal of Physiology. Cell Physiology, 290, C883-C891.
82. Corbel, M., Caulet-Maugendre, S., Germain, N., Molet, S., Lagente, V., & Boichot, E. (2001). Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. Journal of Pathology, 193, 538-545.
83. Martinez, M. L., Castro, M. M., Rizzi, E., Fernandes, K., Demacq, C., Bendhack, L. M., et al. (2008). Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, 591, 224-230.
84. Sen, U., Basu, P., Abe, O. A., Givvimani, S., Tyagi, N., Metreveli, N., et al. (2009). Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. American Journal of Physiology. Renal Physiology, 297, F410-F419.
85. Sen, U., Herrmann, M., Herrmann, W., & Tyagi, S. C. (2007). Synergism between AT1 receptor and hyperhomocysteinemia during vascular remodeling. Clinical Chemistry and Laboratory Medicine, 45, 1771-1776.
86. Laggner, H., Hermann, M., Esterbauer, H., Muellner, M. K., Exner, M., Gmeiner, B. M., et al. (2007). The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. Journal of Hypertension, 25, 2100-2104.